The Patent Finder

Pharmagenesis, Inc.

Also on record
Records under this name other than patents Pharmagenesis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Pharmagenesis, Inc.

PatentTitleStatus Expires Confidence
US 7,863,464Triptolide lactone ring derivatives as immunomodulators and anticancer agents
Lapsed on the fee record
Ended Jan 4, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jan 4, 2023From the USPTO record
US 8,426,616Triptolide lactone ring derivatives as immunomodulators and anticancer agents
Lapsed on the fee record
Ended Apr 23, 2021 · From the USPTO record
Lapsed on the fee recordEnded Apr 23, 2021From the USPTO record
US 8,268,882Triptolide C-ring derivatives as anticancer agents and immune modulators
Lapsed on the fee record
Ended Sep 18, 2020 · From the USPTO record
Lapsed on the fee recordEnded Sep 18, 2020From the USPTO record
US 7,662,976Triptolide derivatives for modulation of apoptosis and immunosuppression
Lapsed on the fee record
Ended Feb 16, 2018 · From the USPTO record
Lapsed on the fee recordEnded Feb 16, 2018From the USPTO record
US 6,991,817Acid-modified arabinogalactan protein composition
Lapsed on the fee record
Ended Jan 31, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jan 31, 2018From the USPTO record
US 8,617,906Identification and screening of triptolide target molecules
Lapsed on the fee record
Ended Dec 31, 2017 · From the USPTO record
Lapsed on the fee recordEnded Dec 31, 2017From the USPTO record
US 6,943,259Halogenated triptolide derivatives as immunomodulators and anticancer agents
Lapsed on the fee record
Ended Sep 13, 2017 · From the USPTO record
Lapsed on the fee recordEnded Sep 13, 2017From the USPTO record
US 7,417,069Halogenated triptolide derivatives as immunomodulators and anticancer agents
Lapsed on the fee record
Ended Aug 26, 2016 · From the USPTO record
Lapsed on the fee recordEnded Aug 26, 2016From the USPTO record
US 8,048,914Methods for isolation of triptolide compounds from Tripterygium wilfordii
Lapsed on the fee record
Ended Nov 1, 2015 · From the USPTO record
Lapsed on the fee recordEnded Nov 1, 2015From the USPTO record
US 6,620,843Anticancer treatment using triptolide prodrugs
Lapsed on the fee record
Ended Sep 16, 2015 · From the USPTO record
Lapsed on the fee recordEnded Sep 16, 2015From the USPTO record
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited